Brain metastases in N2-positive non-small-cell lung cancer

Implications for prophylactic cranial irradiation

Mollit Bansal, Teresa Boyle, Alex Ehsan, Frank Edmund Mott

Research output: Contribution to journalArticle

Abstract

Patients with non-small-cell lung cancer with positive lymph nodes (stage IIIA and IIIB) have an increased risk for brain metastases. Those with nonsquamous histology are at higher risk. Despite this fact, the use of prophylactic cranial irradiation (PCI) has not shown an improvement in survival in these patients and is still considered to be investigational. The Radiation Therapy Oncology Group attempted to prospectively address this in a randomized trial that recently closed because of poor accrual. We present 2 cases and review the literature and provide an argument for the consideration of PCI in select patients.

Original languageEnglish (US)
Pages (from-to)227-229
Number of pages3
JournalClinical Lung Cancer
Volume9
Issue number4
DOIs
StatePublished - Jan 1 2008

Fingerprint

Cranial Irradiation
Non-Small Cell Lung Carcinoma
Neoplasm Metastasis
Brain
Radiation Oncology
Histology
Radiotherapy
Lymph Nodes
Survival

Keywords

  • Chemoradiation
  • Cognitive function
  • Lobectomy
  • Palliation

ASJC Scopus subject areas

  • Oncology
  • Pulmonary and Respiratory Medicine
  • Cancer Research

Cite this

Brain metastases in N2-positive non-small-cell lung cancer : Implications for prophylactic cranial irradiation. / Bansal, Mollit; Boyle, Teresa; Ehsan, Alex; Mott, Frank Edmund.

In: Clinical Lung Cancer, Vol. 9, No. 4, 01.01.2008, p. 227-229.

Research output: Contribution to journalArticle

Bansal, Mollit ; Boyle, Teresa ; Ehsan, Alex ; Mott, Frank Edmund. / Brain metastases in N2-positive non-small-cell lung cancer : Implications for prophylactic cranial irradiation. In: Clinical Lung Cancer. 2008 ; Vol. 9, No. 4. pp. 227-229.
@article{0cd1e7536f1843d4b408e569b21fe11b,
title = "Brain metastases in N2-positive non-small-cell lung cancer: Implications for prophylactic cranial irradiation",
abstract = "Patients with non-small-cell lung cancer with positive lymph nodes (stage IIIA and IIIB) have an increased risk for brain metastases. Those with nonsquamous histology are at higher risk. Despite this fact, the use of prophylactic cranial irradiation (PCI) has not shown an improvement in survival in these patients and is still considered to be investigational. The Radiation Therapy Oncology Group attempted to prospectively address this in a randomized trial that recently closed because of poor accrual. We present 2 cases and review the literature and provide an argument for the consideration of PCI in select patients.",
keywords = "Chemoradiation, Cognitive function, Lobectomy, Palliation",
author = "Mollit Bansal and Teresa Boyle and Alex Ehsan and Mott, {Frank Edmund}",
year = "2008",
month = "1",
day = "1",
doi = "10.3816/CLC.2008.n.034",
language = "English (US)",
volume = "9",
pages = "227--229",
journal = "Clinical Lung Cancer",
issn = "1525-7304",
publisher = "Elsevier",
number = "4",

}

TY - JOUR

T1 - Brain metastases in N2-positive non-small-cell lung cancer

T2 - Implications for prophylactic cranial irradiation

AU - Bansal, Mollit

AU - Boyle, Teresa

AU - Ehsan, Alex

AU - Mott, Frank Edmund

PY - 2008/1/1

Y1 - 2008/1/1

N2 - Patients with non-small-cell lung cancer with positive lymph nodes (stage IIIA and IIIB) have an increased risk for brain metastases. Those with nonsquamous histology are at higher risk. Despite this fact, the use of prophylactic cranial irradiation (PCI) has not shown an improvement in survival in these patients and is still considered to be investigational. The Radiation Therapy Oncology Group attempted to prospectively address this in a randomized trial that recently closed because of poor accrual. We present 2 cases and review the literature and provide an argument for the consideration of PCI in select patients.

AB - Patients with non-small-cell lung cancer with positive lymph nodes (stage IIIA and IIIB) have an increased risk for brain metastases. Those with nonsquamous histology are at higher risk. Despite this fact, the use of prophylactic cranial irradiation (PCI) has not shown an improvement in survival in these patients and is still considered to be investigational. The Radiation Therapy Oncology Group attempted to prospectively address this in a randomized trial that recently closed because of poor accrual. We present 2 cases and review the literature and provide an argument for the consideration of PCI in select patients.

KW - Chemoradiation

KW - Cognitive function

KW - Lobectomy

KW - Palliation

UR - http://www.scopus.com/inward/record.url?scp=49249107723&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=49249107723&partnerID=8YFLogxK

U2 - 10.3816/CLC.2008.n.034

DO - 10.3816/CLC.2008.n.034

M3 - Article

VL - 9

SP - 227

EP - 229

JO - Clinical Lung Cancer

JF - Clinical Lung Cancer

SN - 1525-7304

IS - 4

ER -